nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2A—cerebellar cortex—hypothyroidism	0.0689	0.0844	CbGeAlD
Oxymetazoline—HTR2A—urine—hypothyroidism	0.0366	0.0449	CbGeAlD
Oxymetazoline—NISCH—adrenal cortex—hypothyroidism	0.0313	0.0384	CbGeAlD
Oxymetazoline—NISCH—heart—hypothyroidism	0.0303	0.0371	CbGeAlD
Oxymetazoline—HTR1E—female gonad—hypothyroidism	0.0287	0.0352	CbGeAlD
Oxymetazoline—NISCH—pituitary gland—hypothyroidism	0.0253	0.031	CbGeAlD
Oxymetazoline—HTR2A—nerve—hypothyroidism	0.0253	0.031	CbGeAlD
Oxymetazoline—NISCH—adrenal gland—hypothyroidism	0.0226	0.0277	CbGeAlD
Oxymetazoline—NISCH—blood—hypothyroidism	0.0226	0.0277	CbGeAlD
Oxymetazoline—NISCH—thyroid gland—hypothyroidism	0.0218	0.0267	CbGeAlD
Oxymetazoline—NISCH—female gonad—hypothyroidism	0.0211	0.0258	CbGeAlD
Oxymetazoline—NISCH—testis—hypothyroidism	0.0187	0.0229	CbGeAlD
Oxymetazoline—HTR1B—cardiovascular system—hypothyroidism	0.0184	0.0226	CbGeAlD
Oxymetazoline—HTR2B—adrenal cortex—hypothyroidism	0.0182	0.0223	CbGeAlD
Oxymetazoline—HTR1D—cardiovascular system—hypothyroidism	0.0178	0.0218	CbGeAlD
Oxymetazoline—NISCH—liver—hypothyroidism	0.0177	0.0216	CbGeAlD
Oxymetazoline—HTR2B—heart—hypothyroidism	0.0176	0.0215	CbGeAlD
Oxymetazoline—NISCH—cerebellum—hypothyroidism	0.0172	0.0211	CbGeAlD
Oxymetazoline—HTR2B—cardiovascular system—hypothyroidism	0.0166	0.0203	CbGeAlD
Oxymetazoline—ADRA1A—heart—hypothyroidism	0.0145	0.0178	CbGeAlD
Oxymetazoline—ADRA2C—adrenal cortex—hypothyroidism	0.0143	0.0175	CbGeAlD
Oxymetazoline—ADRA2C—heart—hypothyroidism	0.0138	0.0169	CbGeAlD
Oxymetazoline—ADRA1A—cardiovascular system—hypothyroidism	0.0137	0.0168	CbGeAlD
Oxymetazoline—HTR2B—adrenal gland—hypothyroidism	0.0131	0.0161	CbGeAlD
Oxymetazoline—HTR2B—blood—hypothyroidism	0.0131	0.0161	CbGeAlD
Oxymetazoline—HTR2B—thyroid gland—hypothyroidism	0.0126	0.0155	CbGeAlD
Oxymetazoline—ADRA2C—pituitary gland—hypothyroidism	0.0115	0.0142	CbGeAlD
Oxymetazoline—ADRA2A—heart—hypothyroidism	0.011	0.0135	CbGeAlD
Oxymetazoline—ADRA1A—adrenal gland—hypothyroidism	0.0108	0.0133	CbGeAlD
Oxymetazoline—ADRA1A—blood—hypothyroidism	0.0108	0.0133	CbGeAlD
Oxymetazoline—ADRA2C—adrenal gland—hypothyroidism	0.0103	0.0126	CbGeAlD
Oxymetazoline—ADRA2C—blood—hypothyroidism	0.0103	0.0126	CbGeAlD
Oxymetazoline—ADRA2C—female gonad—hypothyroidism	0.00962	0.0118	CbGeAlD
Oxymetazoline—ADRA2A—gonad—hypothyroidism	0.00944	0.0116	CbGeAlD
Oxymetazoline—HTR2A—heart—hypothyroidism	0.00937	0.0115	CbGeAlD
Oxymetazoline—ADRA2A—pituitary gland—hypothyroidism	0.00921	0.0113	CbGeAlD
Oxymetazoline—HTR2A—cardiovascular system—hypothyroidism	0.00885	0.0108	CbGeAlD
Oxymetazoline—ADRA2C—testis—hypothyroidism	0.00853	0.0105	CbGeAlD
Oxymetazoline—ADRA1A—liver—hypothyroidism	0.00846	0.0104	CbGeAlD
Oxymetazoline—ADRA1A—cerebellum—hypothyroidism	0.00827	0.0101	CbGeAlD
Oxymetazoline—ADRA2A—adrenal gland—hypothyroidism	0.00823	0.0101	CbGeAlD
Oxymetazoline—ADRA2A—blood—hypothyroidism	0.00823	0.0101	CbGeAlD
Oxymetazoline—ADRA2C—liver—hypothyroidism	0.00806	0.00989	CbGeAlD
Oxymetazoline—HTR2A—gonad—hypothyroidism	0.00803	0.00984	CbGeAlD
Oxymetazoline—ADRA2A—thyroid gland—hypothyroidism	0.00794	0.00974	CbGeAlD
Oxymetazoline—ADRA2C—cerebellum—hypothyroidism	0.00788	0.00966	CbGeAlD
Oxymetazoline—HTR2A—pituitary gland—hypothyroidism	0.00783	0.0096	CbGeAlD
Oxymetazoline—ADRA2A—female gonad—hypothyroidism	0.00767	0.00941	CbGeAlD
Oxymetazoline—HTR2A—adrenal gland—hypothyroidism	0.007	0.00858	CbGeAlD
Oxymetazoline—HTR2A—blood—hypothyroidism	0.007	0.00858	CbGeAlD
Oxymetazoline—ADRA2A—testis—hypothyroidism	0.00681	0.00834	CbGeAlD
Oxymetazoline—ADRA2A—cerebellum—hypothyroidism	0.00629	0.00771	CbGeAlD
Oxymetazoline—HTR2A—testis—hypothyroidism	0.00579	0.0071	CbGeAlD
Oxymetazoline—HTR2A—liver—hypothyroidism	0.00547	0.00671	CbGeAlD
Oxymetazoline—HTR2A—cerebellum—hypothyroidism	0.00534	0.00655	CbGeAlD
Oxymetazoline—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	0.000332	0.0018	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000332	0.0018	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000332	0.0018	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—TSHB—hypothyroidism	0.000326	0.00177	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—TSHR—hypothyroidism	0.000326	0.00177	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	0.000325	0.00176	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—SH2B3—hypothyroidism	0.000324	0.00176	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000323	0.00175	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—TSHB—hypothyroidism	0.000322	0.00175	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—TSHR—hypothyroidism	0.000322	0.00175	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—VAV3—hypothyroidism	0.000321	0.00174	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CLTC—hypothyroidism	0.00032	0.00173	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—POMC—hypothyroidism	0.000318	0.00173	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CLTC—hypothyroidism	0.000313	0.0017	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—POMC—hypothyroidism	0.000312	0.00169	CbGpPWpGaD
Oxymetazoline—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000311	0.00169	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00031	0.00168	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.00031	0.00168	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.00031	0.00168	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—AVP—hypothyroidism	0.000309	0.00167	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	0.000308	0.00167	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	0.000302	0.00164	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	0.000302	0.00164	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000302	0.00164	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—TRH—hypothyroidism	0.000302	0.00164	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—TSHB—hypothyroidism	0.000301	0.00163	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—TSHR—hypothyroidism	0.000301	0.00163	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000297	0.00161	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	0.000296	0.00161	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	0.000296	0.00161	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000296	0.0016	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000296	0.0016	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	0.000295	0.0016	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CLTC—hypothyroidism	0.000294	0.0016	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—POMC—hypothyroidism	0.000293	0.00159	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	0.00029	0.00157	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	0.00029	0.00157	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—VAV3—hypothyroidism	0.000281	0.00152	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	0.000281	0.00152	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TRH—hypothyroidism	0.000276	0.0015	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—VAV3—hypothyroidism	0.000275	0.00149	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	0.000274	0.00149	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CLTC—hypothyroidism	0.000274	0.00148	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—POMC—hypothyroidism	0.000272	0.00148	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	0.000271	0.00147	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TRH—hypothyroidism	0.000271	0.00147	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000269	0.00146	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000269	0.00146	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000269	0.00146	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000269	0.00146	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000269	0.00146	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—POMC—hypothyroidism	0.000265	0.00144	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	0.000265	0.00144	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000264	0.00143	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	0.000263	0.00143	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	0.000263	0.00143	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—VAV3—hypothyroidism	0.000261	0.00141	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000258	0.0014	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	0.000255	0.00138	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.000254	0.00138	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	0.00025	0.00135	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.000249	0.00135	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	0.000247	0.00134	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TSHB—hypothyroidism	0.000246	0.00134	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TSHR—hypothyroidism	0.000246	0.00134	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	0.000246	0.00133	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—AVP—hypothyroidism	0.000246	0.00133	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000245	0.00133	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	0.000245	0.00133	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	0.000245	0.00133	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TSHB—hypothyroidism	0.000241	0.00131	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TSHR—hypothyroidism	0.000241	0.00131	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—POMC—hypothyroidism	0.000241	0.00131	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—AVP—hypothyroidism	0.000241	0.00131	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—VAV3—hypothyroidism	0.000241	0.0013	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—PRL—hypothyroidism	0.00024	0.0013	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000237	0.00129	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TRH—hypothyroidism	0.000237	0.00128	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000236	0.00128	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000235	0.00127	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	0.000232	0.00126	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	0.000231	0.00125	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	0.00023	0.00125	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	0.000227	0.00123	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.000227	0.00123	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.000227	0.00123	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	0.000226	0.00123	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.000226	0.00123	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—VAV3—hypothyroidism	0.000222	0.00121	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	0.00022	0.00119	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	0.000218	0.00118	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000217	0.00118	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	0.000215	0.00117	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AVP—hypothyroidism	0.000214	0.00116	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TRH—hypothyroidism	0.000214	0.00116	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—TSHB—hypothyroidism	0.000213	0.00115	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—IGF1—hypothyroidism	0.000212	0.00115	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	0.000211	0.00114	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	0.000211	0.00114	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	0.00021	0.00114	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	0.000209	0.00113	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000209	0.00113	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CLTC—hypothyroidism	0.000206	0.00112	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TRH—hypothyroidism	0.000205	0.00111	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—POMC—hypothyroidism	0.000205	0.00111	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000203	0.0011	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	0.000202	0.0011	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	0.000202	0.00109	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	0.000201	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	0.000201	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	0.0002	0.00108	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TRH—hypothyroidism	0.0002	0.00108	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—IGF1—hypothyroidism	0.000198	0.00107	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	0.000197	0.00107	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TRH—hypothyroidism	0.000196	0.00106	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	0.000195	0.00106	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	0.000192	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	0.00019	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	0.00019	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	0.00019	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	0.00019	0.00103	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	0.000189	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	0.000188	0.00102	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	0.000188	0.00102	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	0.000187	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	0.000184	0.000999	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TSHB—hypothyroidism	0.000183	0.000991	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TSHR—hypothyroidism	0.000183	0.000991	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AVP—hypothyroidism	0.000182	0.000989	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	0.000181	0.000983	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000181	0.000982	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	0.00018	0.000975	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TRH—hypothyroidism	0.000178	0.000966	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	0.000178	0.000964	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	0.000178	0.000964	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	0.000177	0.000962	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000177	0.000961	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	0.000176	0.000955	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	0.000175	0.000949	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	0.000175	0.000949	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	0.000175	0.000947	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	0.000174	0.000946	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TRH—hypothyroidism	0.000174	0.000946	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—TSHB—hypothyroidism	0.000173	0.000937	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	0.000171	0.000926	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	0.00017	0.00092	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	0.000165	0.000897	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000165	0.000893	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	0.000164	0.000891	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—POMC—hypothyroidism	0.000163	0.000886	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	0.000163	0.000884	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PRL—hypothyroidism	0.000163	0.000883	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TRH—hypothyroidism	0.000162	0.000879	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	0.000161	0.000873	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—IGF1—hypothyroidism	0.000161	0.00087	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—POMC—hypothyroidism	0.00016	0.000867	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PRL—hypothyroidism	0.00016	0.000865	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—SLC5A5—hypothyroidism	0.000159	0.000863	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TSHB—hypothyroidism	0.000159	0.000861	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TSHR—hypothyroidism	0.000159	0.000861	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	0.000159	0.00086	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	0.000159	0.000859	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AVP—hypothyroidism	0.000158	0.000859	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	0.000156	0.000846	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	0.000155	0.000843	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	0.000155	0.000843	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	0.000155	0.000841	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	0.000154	0.000835	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	0.000154	0.000835	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VAV3—hypothyroidism	0.000151	0.000817	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—POMC—hypothyroidism	0.00015	0.000815	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PRL—hypothyroidism	0.00015	0.000813	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	0.00015	0.000811	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VAV3—hypothyroidism	0.000148	0.0008	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AVP—hypothyroidism	0.000145	0.000787	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	0.000144	0.000783	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	0.000144	0.000783	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	0.000144	0.000781	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—POMC—hypothyroidism	0.000142	0.000772	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AVP—hypothyroidism	0.000142	0.000771	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	0.000142	0.000767	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	0.00014	0.000758	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PRL—hypothyroidism	0.000139	0.000756	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	0.000139	0.000754	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VAV3—hypothyroidism	0.000139	0.000752	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	0.000139	0.000751	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IGF1—hypothyroidism	0.000137	0.000742	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AVP—hypothyroidism	0.000134	0.000724	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	0.000134	0.000724	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	0.00013	0.000704	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—SLC5A5—hypothyroidism	0.000129	0.000701	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	0.000129	0.000699	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	0.000129	0.000698	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	0.000128	0.000693	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	0.000126	0.000684	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PRL—hypothyroidism	0.000126	0.000683	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AVP—hypothyroidism	0.000124	0.000674	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—POMC—hypothyroidism	0.000121	0.000657	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PRL—hypothyroidism	0.000121	0.000656	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	0.000118	0.000639	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PRL—hypothyroidism	0.000118	0.000638	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	0.000116	0.000631	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	0.000116	0.000629	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	0.000116	0.000629	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PRL—hypothyroidism	0.000116	0.000628	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	0.000114	0.000615	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AVP—hypothyroidism	0.000112	0.000608	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VAV3—hypothyroidism	0.000112	0.000606	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	0.000109	0.00059	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AVP—hypothyroidism	0.000108	0.000584	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	0.000107	0.000581	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	0.000105	0.000572	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—POMC—hypothyroidism	0.000105	0.000571	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PRL—hypothyroidism	0.000105	0.000569	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AVP—hypothyroidism	0.000105	0.000568	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AVP—hypothyroidism	0.000103	0.000559	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	0.000103	0.000559	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PRL—hypothyroidism	0.000103	0.000557	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VAV3—hypothyroidism	9.71e-05	0.000527	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—POMC—hypothyroidism	9.65e-05	0.000523	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	9.58e-05	0.000519	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PRL—hypothyroidism	9.55e-05	0.000518	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	9.51e-05	0.000516	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—POMC—hypothyroidism	9.45e-05	0.000512	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AVP—hypothyroidism	9.36e-05	0.000507	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IGF1—hypothyroidism	9.28e-05	0.000503	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AVP—hypothyroidism	9.16e-05	0.000497	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IGF1—hypothyroidism	9.09e-05	0.000493	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—POMC—hypothyroidism	8.88e-05	0.000481	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	8.84e-05	0.000479	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IGF1—hypothyroidism	8.54e-05	0.000463	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AVP—hypothyroidism	8.51e-05	0.000462	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—POMC—hypothyroidism	8.33e-05	0.000452	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—POMC—hypothyroidism	8.26e-05	0.000448	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	7.95e-05	0.000431	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—POMC—hypothyroidism	7.46e-05	0.000404	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	7.17e-05	0.000389	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—POMC—hypothyroidism	7.16e-05	0.000388	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—POMC—hypothyroidism	6.97e-05	0.000378	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IGF1—hypothyroidism	6.89e-05	0.000373	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—POMC—hypothyroidism	6.86e-05	0.000372	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—POMC—hypothyroidism	6.77e-05	0.000367	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	6.7e-05	0.000363	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	6.59e-05	0.000358	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—POMC—hypothyroidism	6.22e-05	0.000337	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—POMC—hypothyroidism	6.09e-05	0.00033	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IGF1—hypothyroidism	5.98e-05	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	5.86e-05	0.000318	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—POMC—hypothyroidism	5.66e-05	0.000307	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	5.44e-05	0.000295	CbGpPWpGaD
